Click to Share
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
News By Tag
Pharmaceuticals Remove
Related Tags

November 2015
Tu Mo Su Sa Fr Th We
24 23 22 21 20 19 18

pharmaceuticals Press Releases

  + XML/RSS  

By AhR Pharmaceuticals, Inc.
AhR Pharmaceuticals Announces the Issuance of its Japan Patent on ITE for Cancer Intervention and Possible Eradication by the Japan Patent Office (JPO)
By Metrics Inc.
In a poster presentation at AAPS, Dr. Brad Gold at Metrics Contract Services demonstrates that two propellants commonly used in prescription inhalers are exhaled primarily unchanged
By Mayne Pharma USA
With more than 25 years of pharmaceutical industry experience, Lewis brings to his role expertise in new chemical entity development, API and dosage form manufacturing, generic drug development and contract services.
By Q1 Productions
Executive Leadership, Payers, Regulatory, Research and Development Among Session and Panel Perspectives
By marcus evans
Inviting Heads, VPs, Directors, Managers, and Specialists of Labeling and Regulatory Affairs from leading pharmaceutical and biotech companies to discuss best practices for generic label documentation
By Virtue Insight
7th Pharmacovigilance 2014 “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management"
By sambria pharmaceuticals
The topical pain relief cream is now Available in America’s High Volume Convenience Stores
By sambria
Sambria Pharmaceuticals is now in process of forming strategic alliances with aesthetic medicine device manufacturers and distributors to provide its topical anesthetic, NeuroMed7 to people having minimally invasive cosmetic procedures.
By sambria
Revenue Forward View As Sambria Pharmaceuticals continues to increase its rapidly growing sales force, distribution partnerships, international strategic alliances and web marketing presence, its outlook for future revenue growth continues to expand at a.
By sambria
Sambria Pharmaceuticals has recently begun exporting its topical anesthetics to many Caribbean Islands as well as Central American nations through its trade partner, Quantum Pharmaceuticals.
By Amyndas Pharmaceuticals
Amyndas Pharmaceuticals SA, the complement therapeutics company, announced that the European Medicines Agency (EMA) has granted AMY-101, a potent complement C3 inhibitor, an Orphan Drug Designation for the treatment of Paroxysmal Nocturnal Hemoglobinuria.
By ELC Group
Internationally acclaimed clinical pharmacologist joins global regulatory affairs specialist in key management post
By Mettler-Toledo International Inc.
METTLER TOLEDO Launches New Differential Scanning Calorimeter DSC 2 for Outstanding Measurement Performance in the Laboratory
By Tech Collective
Second annual industry-specific awards program honors four bioscience champions in consulting and testing, digital health, and education.
By Spectrum Regulatory Solutions
Spectrum Regulatory Solutions, a company that provides a full-service consultancy to the healthcare industry, appoints two new medical writers to further expand its busy team, headed up by Dr Simon Thorn, Scientific Affairs Director.
By Mary Ann Liebert, Inc. publishers
We have pills to ease pain, to cure infection, to help us lose weight, to treat chronic conditions, and to enhance our sexual and athletic prowess. Why do pills play such a central role in today's society and could we benefit from taking fewer pills?
By PharmSource
PharmSource trend report shows 'battle of formulary access' expanding to U.S.
By Ariel Fernandez Consultancy
Protein structural defects are key players in enzyme catalysis
By Metrics Inc.
New spray dryer allows company to render powder from solution, and modify particle sizes
By marcus evans
Interview with Richard DiCicco, Chairman with Harvest Moon Pharmaceuticals, on key topics to be discussed at the upcoming marcus evans 7th Product & Pipeline Enhancement for Generics Conference, on July 30-31, 2014 in Alexandria, VA
The biotech/biopharma industry has been a core leader in the healthcare market for organic job creation thus fueling positive economic impact.
By Netscribes.Inc
Netscribes, Inc. launches a report on Cardiovascular Pharmaceutical Market in India 2014 covering a market with strong growth potential. It is a part of Netscribes’ Healthcare Series.
By Metrics Inc.
Natasha Savage has 15 years of pharma experience, including working as analytical chemist
As one of the industry leaders in the healthcare sector - Novartis' new business structure and smaller portfolio may result in an increase in profits.
By Mayne Pharma USA
He brings 15+ years of pharma industry experience in strategic planning, mergers and acquisitions, and product in-licensing and out-licensing
By SMi Group Ltd
Evaluate HTA Reforms and Market Access Processes to Optimise Business Profit | 13-14 October 2014
By SMi Group Ltd
Join SMi Group's second annual Lyophilisation forum taking place on 7-8 July, London, and gain insight into current successes and challenges that leading pharmaceutical and biotechnology organisations are facing during their freeze drying life cycles
By Arrowhead Publishers
The 3rd Annual Drug Repositioning, Repurposing and Rescue Conference will be held on July 15 & 16, 2014 and will focus on explorations into new therapeutics entities; crowd funding and collaborative drug discovery and development.
By SMi Group Ltd
As many pharmaceutical companies’ needs for growing their pipelines rise, this is fuelling the increase in partnerships with external groups – academia, biotech and funding organisations.
By SMi Group Ltd
As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access to Medicines Scheme was introduced.
By SMi Group Ltd
SMi Group reports: Leading experts will be meeting in London at the Clinical Trial Logistics conference taking place in one week's time
By SMi Group
| Latest attendees Johnson & Johnson, Biogen and Roche - Two-day event to take place 12th - 13th May 2014 - Targeted workshops to take place on 14th May
By American Conference Institute
American Conference Institute (“ACI”) is pleased to announce that Keith Flanagan, Transition Lead for Policy at the United States Food and Drug Administration’s Office of Generic Drugs will give a keynote address at ACI’s Second Annual Legal and...
By Virtue Insight
5th Annual Clinical Trials Summit 2014 "A critical guide for successfully conducting clinical trials” 10th & 11th June 2014, Kohinoor Continental Hotel, Mumbai, India
By ePharmahub.Com
ePharma Hub is a unique pharma marketplace that integrates needs and intent of customers, suppliers and all ancillary service providers of pharmaceutical products and services over homogeneous information, communication and transactions.
By SMi Group Ltd
Due to the increasing complexity of bringing biosimilars from the lab to the global market, the increasing number of partnerships in the past year has been on a steep rise.
By CP Lab Safety
CP Lab Safety celebrates Earth Day with a new blog that provides resources for managing expired pharmaceuticals, cosmetics, and more.
By VIO Chemicals AG
The new GMP plant of VIO Chemicals AG at Binhai, China has passed the first two GMP audits and is now ramping up for production of custom intermediates for APIs.
By Olympia Pharmacy
Olympia Compounding Pharmacy announced today it has voluntarily registered with the FDA as an outsourcing facility.
By OsoBio
Buck has 20-plus years of experience managing pharma and commercial manufacturing plants
By marcus evans
Top Pharmaceutical and Biotech Representatives to Discuss the Current Complexities and Key Challenges in Pharmacovigilance, May 6-7, 2014 in Philadelphia, PA
By Incentius
Amit Jain, a Sales Compensation & Analytics expert with 10+ years experience in various practice areas within sales and marketing function joins Incentius Team as Partner
By Bharat Book Bureau announces a new report on "Global Peptide Therapeutics Market & Pipeline Insight" which very significant role in modulating cell functions, peptides are used in many physiological and pathological processes.
By Bharat Book Bureau announces a new report on "US Orphan Drug Market Outlook" which largest market for orphan drugs, USA, there was a shortage of adequate therapies for treating many rare diseases.
By Bharat Book Bureau announces a new report on "Europe Orphan Drug Market Outlook 2018" which concept of rare diseases and the idea that a special attention needs to be given to this sector has been taking shape in Europe since the 1990s.
By Metrics Inc.
Along with Gerteis Mini-Pactor®, capital investments reflect ongoing commitment to contract services
By SMi Group
Two-day event to take place 12th - 13th May 2014 in London, UK
By Metrics Inc.
Mayne Pharma USA has acquired select brands from Forest Laboratories Inc. for $10M plus $2M performance-based earn-out; purchase complements brand acquisition from Shionogi completed in November 2013
By SMi Online
Two-day event to take place 23rd - 24th June 2014 in London featuring leading biobanking specialists
By BioCapacity On Demand, LLC
Co-Manufacturing Agreement between BioCapacity On Demand and Medical Coaches Reached

Page updated every 10 minutes

Like PRLog?
Click to Share